UK clinical trials - updated daily from ClinicalTrials.gov
Understand the key differences between small cell lung cancer and non-small cell lung cancer clinical trials and research opportunities
Aggressive neuroendocrine tumour, ~15% of lung cancers. Limited trial options but immunotherapy+chemotherapy combinations are showing promise.
The most common lung cancer type. Extensive biomarker-driven trial activity (EGFR, ALK, ROS1, KRAS, PD-L1) with targeted therapies and immunotherapy.
SCLC has far fewer trials and treatment options. NSCLC has become a model for precision oncology with biomarker-guided treatment pathways.
Search our database of 29,000+ UK clinical trials matched to your condition and profile
Browse Disease PathwaysData sourced from ClinicalTrials.gov. Trial counts are approximate and updated regularly.
TrialConnect is a trading name of Clinical Vendor Compare Limited.
